د. خالد العدل هو أستاذ الكيمياء الصيدلية وتصميم الأدوية ورئيس قسم الكيمياء الصيدلية بكلية الصيدلة وتكنولوجيا الدواء بجامعة هليوبوليس للتنمية المستدامة. حصل على درجة البكالوريوس في عام ١٩٩٨ والماجستير عام ٢٠٠٤ و الدكتوراه عام ٢٠٠٩ من جامعة الأزهر.

قبل التحاقه بجامعة هليوبوليس ، عمل د. العدل أستاذاً مساعداً في الكيمياء الصيدلية وتصميم الأدوية في جامعة النهضة ببني سويف. ومن أكتوبر ٢٠١٤ حتى يناير ٢٠١٨ شغل نفس المنصب في جامعة الأزهر. بالإضافة إلى ذلك ، يشغل حالياً منصب مدير وحدة التحاليل الصيدلانية بجامعة الأزهر ومستشارًا في لجنة الجودة للإدارة المركزية لشئون الصيادلة من أجل منح ترخيص أدوية فيروس C والأورام السرطانية.

يعمل د. العدل مراجعاً لعدد من الدوريات العلمية منها:

كما شارك في عدد كبير من المؤتمرات العلمية منها:

  • Al-Azhar International Conference of Pharmacy and Biotechnology Dec. 19-21, 2004.
  • Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, Feb. 13-15, 2006.
  • The 7th National TEMPUS Day – the 5th TEMPUS Projects Forum (2009).
  • Best poster in the 13th IBN SINA International Conference on Pure and Applied Heterocyclic Chemistry- Heterocyclic Chemistry for Sustainable Future 2015 (Department of Chemistry – Faculty of Science – Sohag University).
  • 13th International Conference on Chemistry and its Role in Development 2017 (Department of Chemistry, Faculty of Science, Mansoura University).
  • Al-Azhar 5th International Conference of Pharmaceutical Sciences and Drug Industries (AICPD) 2017.

الأوراق البحثية:

  • El-Helby AA, Ibrahim MK, El-Zahaby MAA, Monir AA, El-Adl K. Synthesis and Anticonvulsant Activity Of Some New derivatives of benzoxazole-2-thiol, Egypt J. Biomed. Sci., (2003);11:60-73,.
  • El-Helby AA, Ibrahim MK, Abdel-Rahman AA, Ayyad RRA, Menshawy MA, El-Adl K. Synthesis, molecular modeling and Anticonvulsant Activity of benzoxazole derivatives, Al-Azhar J. Pharm. Sci., (2009);40:252-270.
  • Ibrahim MK, Abdel-Rahman AA, Ayyad RRA, El-Adl K, Elsherbeny F, Rashed M. Design and Synthesis of Some Novel N-Phthalimide derivatives With Potential Anticonvulsant Activity, Al-Azhar J. Pharm. Sci., (2010);42:305-322.
  • El-Adl K. Design and Synthesis of Some Novel 2-(5-Methyl-Benzoxazole-2-ylsufanyl)-N-(4-substitutedphenyl)-acetamide derivatives with Potential Anticonvulsant Activity, Al-Azhar J. Pharm. Sci., (2011);44:305-322,.
  • Ibrahim MK, El-Adl K, Al-Karmalawy AA. Design, synthesis, molecular docking and biological evaluation of some novel Quinazolin-4(3H)-one derivatives as anti-inflammatory agents. Azhar Pharm. Sci. (2012);46:185-203.
  • Zayed MF, Ahmed HEA, Omar AM, Abdelrahim AS, El-Adl K. Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents. Medicinal Chemistry Research (2013);22(12):5823-5831.
  • Ibrahim MK, Abd-Elrahman AA, Ayyad RRA, El-Adl K, Mansour AM, Eissa IH. Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)yl)-N-(4-(substituted)phenyl)acetamide derivatives for biological evaluation as anticonvulsant agents. Bulletin of Faculty of Pharmacy, Cairo University (2013);51:101-111.
  • Ibrahim MK, El-Adl K, Zayed MF, Mahdy HA. Design, synthesis and biological evaluation of some novel 5-chloro-2-substitutedsulfanyl-benzoxazole derivatives as anticonvulsant agents. Medicinal Chemistry Research (2015);24:99–114. DOI: 1007/s00044-014-1111-0
  • Ibrahim MK, El-Adl K, Al-Karmalawy AA. Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4(3H)-one Bulletin of Faculty of Pharmacy, Cairo University (2015);53:101–116. DOI: 10.1016/j.bfopcu.2015.05.001
  • El-Helby AA, Ayyad RRA, El-Adl K, Sakr H, Abdel-Rahman AA, Essa IH, Elwan A. Design, molecular docking and synthesis of some novel 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-one derivatives for anticonvulsant evaluation as AMPA-receptor antagonists. Medicinal Chemistry Research (2016); 25:3030–3046. DOI: 1007/s00044-016-1723-7
  • Abulkhair HS, El-Gamal KM, El-Adl K, Fadl MF. Molecular Docking, synthesis and biological evaluation of some novel 2-substituted-3-allyl-4(3h)-quinazolinone derivatives as anticonvulsant agents. Med Chem (Los Angeles) 2016; 6(9): 593-603. Doi:4172/2161-0444.1000404
  • Zayed MF, Ihmaid SK, Ahmed HEA, El-Adl K, Asiri AM, Omar AM. Synthesis, modelling, and anticonvulsant studies of new quinazolines showing three highly active compounds with low toxicity and high affinity to the GABA-A receptor. Molecules (2016); 22(188):1-15. DOI:3390/molecules22020188
  • El-Helby AA, Ayyad RRA, Sakr H, Abdel-Rahman AS, El-Adl K, Elsherbeny F, Essa IH, Khalifa MM. Design, synthesis, molecular modeling and biological evaluation of novel 2,3-dihydrophthalazine-1,4-dione derivatives as potential anticonvulsant agents. J Molecular Structure (2017);1130:333-351. DOI: 1016/j.molstruc.2016.10.052
  • El-Helby AA, Ayyad RRA, El-Adl K, Elwan A. Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity. Medicinal Chemistry Research (2017); 26:2967– DOI: 10.1007/s00044-017-1996-5
  • El-Helby AA, Ayyad RRA, Sakr H, El-Adl K, Mamdouh MA, Khedr F. Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors. Arch. Pharm. Chem. Life Sci. (2017):350:1-16. DOI: 1002/ardp.201700240
  • El-Helby AA, Ayyad RRA, Sakr H, El-Adl K, Mamdouh MA, Khedr F. Design, synthesis, in vitro anti-cancer activity, ADMET profile and molecular docking of novel triazolo[3,4-a]phthalazine derivatives targeting VEGFR-2 enzyme. Anticancer agents in Med. Chem. (2018):18; DOI: 2174/1871520618666180412123833
  • El-Helby AA, Ayyad RRA, El-Adl K, Hazem Elkady. Phthalazine-1,4-dione derivatives as non-competitive AMPA-receptor antagonists: Design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Molecular Diversity (2018): 1-6 DOI : 10.1007/s11030-018-9871-y